Trial Profile
A Randomized, Observer Blinded, Controlled Trial to Evaluate the Safety and Immunogenicity of a New Formulation of Euvichol (Killed Bivalent Whole Cell Oral Cholera Vaccine Manufactured by EuBiologics Co. Ltd.) in Healthy Individuals
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Jul 2018
Price :
$35
*
At a glance
- Drugs Cholera vaccine inactivated (Primary)
- Indications Cholera
- Focus Pharmacodynamics
- 09 Jun 2018 Status changed from not yet recruiting to completed, according to results published in the Vaccine.
- 09 Jun 2018 Results (n=442) published in the Vaccine.
- 16 Dec 2015 Planned End Date changed from 1 Apr 2016 to 1 Aug 2016 as per ClinicalTrials.gov record.